LGD-1550 Uses, Dosage, Side Effects and more
LGD-1550 is an orally-active synthetic aromatic retinoic acid agent with potential antineoplastic and chemopreventive activities.
| Attribute | Details |
|---|---|
| Trade Name | LGD-1550 |
| Generic | LGD-1550 |
| Type | |
| Formula | C23H32O2 |
| Weight | Average: 340.507 Monoisotopic: 340.24023027 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in cancer/tumors (unspecified).
How LGD-1550 works
LGD 1550 selectively binds to all three retinoic acid receptors (RAR-alpha, RAR-beta, and RAR-gamma), resulting in alterations in the expression of genes responsible for cell differentiation and proliferation. This agent also acts as an inhibitor of activator protein 1 (AP-1), a protein that mediates trophic responses and malignant transformation.
